Literature DB >> 25272090

Age- and gender-related changes in glucose homeostasis in glucocorticoid-treated rats.

Cristiane dos Santos1, Francielle Batista D Ferreira, Luiz M Gonçalves-Neto, Sebastião Roberto Taboga, Antonio Carlos Boschero, Alex Rafacho.   

Abstract

The disruption to glucose homeostasis upon glucocorticoid (GC) treatment in adult male rats has not been fully characterized in older rats or in females. Thus, we evaluated the age- and gender-related changes in glucose homeostasis in GC-treated rats. We injected male and female rats at 3 months and 12 months of age with either dexamethasone (1.0 mg/kg body mass, intraperitoneally) or saline, daily for 5 days. All of the GC-treated rats had decreased body mass and food intake, and adrenal hypotrophy. Increased glycemia was observed in all of the GC-treated groups and only the 3-month-old female rats were not glucose intolerant. Dexamethasone treatment resulted in hyperinsulinemia and hypertriacylglyceridemia in all of the GC-treated rats. The glucose-stimulated insulin secretion (GSIS) was higher in all of the dexamethasone-treated animals, but it was less pronounced in the older animals. The β-cell mass was increased in the younger male rats treated with dexamethasone. We conclude that dexamethasone treatment induces glucose intolerance in both the 3- and 12-month-old male rats as well as hyperinsulinemia and augmented GSIS. Three-month-old female rats are protected from glucose intolerance caused by GC, whereas 12-month-old female rats developed the same complications that were present in 3- and 12-month-old male rats.

Entities:  

Keywords:  dexamethasone; dexaméthasone; female; femelle; glucose tolerance; insulin secretion; insulin sensitivity; sensibilité à l’insuline; sécrétion d’insuline; tolérance au glucose

Mesh:

Substances:

Year:  2014        PMID: 25272090     DOI: 10.1139/cjpp-2014-0259

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  6 in total

1.  Prevention of Elevation in Plasma Triacylglycerol with High-Dose Bezafibrate Treatment Abolishes Insulin Resistance and Attenuates Glucose Intolerance Induced by Short-Term Treatment with Dexamethasone in Rats.

Authors:  Maiara Destro Inácio; Alex Rafacho; Nathália Aparecida de Paula Camaforte; Poliana Teixeira; Priscilla Maria Ponce Vareda; Natália Moretti Violato; José Roberto Bosqueiro
Journal:  Int J Endocrinol       Date:  2018-11-08       Impact factor: 3.257

2.  Sex differences in body composition, metabolism-related hormones, and energy homeostasis during aging in Wistar rats.

Authors:  Susana Quirós Cognuck; Wagner L Reis; Marcia Silva; Lucas K Debarba; Andre S Mecawi; Francisco J A de Paula; Celso Rodrigues Franci; Lucila L K Elias; Jose Antunes-Rodrigues
Journal:  Physiol Rep       Date:  2020-10

Review 3.  Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence.

Authors:  Aoibhe M Pasieka; Alex Rafacho
Journal:  Metabolites       Date:  2016-08-03

4.  Dexamethasone Administration During Late Gestation Has No Major Impact on Lipid Metabolism, but Reduces Newborn Survival Rate in Wistar Rats.

Authors:  Katia Motta; Patricia R L Gomes; Paola M Sulis; Silvana Bordin; Alex Rafacho
Journal:  Front Physiol       Date:  2018-07-03       Impact factor: 4.566

5.  Glucose Homeostasis Is Not Affected in a Murine Model of Parkinson's Disease Induced by 6-OHDA.

Authors:  Felipe Azevedo Gomes; Rafael Appel Flores; Maciel Alencar Bruxel; Flávia Natividade da Silva; Eduardo Luiz Gasnhar Moreira; Daniel Breseghello Zoccal; Rui Daniel Prediger; Alex Rafacho
Journal:  Front Neurosci       Date:  2019-01-09       Impact factor: 4.677

6.  Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons.

Authors:  Erika Harno; Charlotte Sefton; Jonathan R Wray; Tiffany-Jayne Allen; Alison Davies; Anthony P Coll; Anne White
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.